Yearly Archives: 2026
London Stock Exchange: Biggest Changes to AIM Rules in Two Decades
For more than 30 years, AIM has been Europe’s most successful growth market.
Receptor.AI, Sethera Plan to Create Closed-Loop Discovery, Optimization Workflow for Difficult Therapeutic Targets
Receptor.AI and Sethera partner to create a closed-loop drug discovery workflow.
Roche Advances AI-Derived Drug with Partner Recursion
The Recursion option follows several years of work building what Recursion calls “maps of biology.“
Ratio Therapeutics Closes $70M Series C Financing
Round brings total capital raised to over $240M.
Dash Bio Raises $30M Series A to Accelerate Drug Development Timelines
Funding Brings Total Raised to $47.5M as Demand Grows for Better Infrastructure to Support Biopharma
Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test
Submission includes a concurrent CLIA Waiver by Application for use of the test on the Co-Dx PCR Pro® instrument in decentralized point-of-care settings.
Co-Diagnostics Raises Capital Through Warrant Inducement Ahead of FDA Review
A company still awaiting its first FDA clearance just structured a capital raise around the urgency of that wait. On July 30, 2026, Co-Diagnostics, Inc. entered into a warrant inducement agreement with existing warrant holders, convincing them to exercise warrants early in exchange for new warrants at revised terms. The transaction is straightforward on its […]
ARUP Laboratories Adds Cyclospora Data to Infectious Disease Dashboard Amid National Outbreak
ARUP Laboratories observed Cyclospora positivity rates increase from very low levels to unprecedented levels within a short period of time.
Fluidx Medical Closes Financing to Advance Next-Generation Embolic Platform
Investment will support commercialization of GPX and ULTRA Embolic Devices and development of IMPASS neurovascular platform.
Canyon Labs Invests in Commercial Leadership to Give Medical Device Manufacturers Direct Access to Expertise
Canyon Labs strengthens its commitment to medical device manufacturers with strategic, direct-access leadership investments.
SINTX Technologies Engages Veteran MedTech Executive Chris Lyons and Southern Metrics to Establish Strategic Opportunity Management Program
Southern Metrics is led by Chris Lyons, its Chief Executive Officer, an experienced medical technology executive and strategic advisor who has served on the SINTX Board of Directors since April 2025.
CancerVax Named a Top Preclinical Biotech Company of 2026 by Life Sciences Review
Independent industry recognition highlights the Company’s revolutionary immunotherapy platform and growing momentum in precision cancer treatment.
